ENTASIS THERAPEUTICS HLDGS I's ticker is ETTX and the CUSIP is 293614103. A total of 28 filers reported holding ENTASIS THERAPEUTICS HLDGS I in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,106,000 | +22.2% | 502,622 | +3.9% | 0.00% | – |
Q1 2022 | $905,000 | -8.2% | 483,723 | +7.5% | 0.00% | – |
Q4 2021 | $986,000 | -30.8% | 449,955 | +5.6% | 0.00% | – |
Q3 2021 | $1,424,000 | +27.0% | 426,235 | +1.5% | 0.00% | – |
Q2 2021 | $1,121,000 | +155.4% | 419,997 | +104.7% | 0.00% | – |
Q1 2021 | $439,000 | +33.4% | 205,166 | +54.1% | 0.00% | – |
Q4 2020 | $329,000 | +63.7% | 133,159 | +34.8% | 0.00% | – |
Q3 2020 | $201,000 | +24.8% | 98,759 | +81.1% | 0.00% | – |
Q2 2020 | $161,000 | +11.8% | 54,526 | 0.0% | 0.00% | – |
Q1 2020 | $144,000 | -46.9% | 54,526 | 0.0% | 0.00% | – |
Q4 2019 | $271,000 | -14.8% | 54,526 | 0.0% | 0.00% | – |
Q3 2019 | $318,000 | +0.3% | 54,526 | +11.1% | 0.00% | – |
Q2 2019 | $317,000 | -4.5% | 49,097 | 0.0% | 0.00% | – |
Q1 2019 | $332,000 | +66.0% | 49,097 | 0.0% | 0.00% | – |
Q4 2018 | $200,000 | – | 49,097 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 1,349,953 | $8,046,000 | 2.52% |
Novo Holdings A/S | 2,181,843 | $13,004,000 | 2.23% |
Sofinnova Investments, Inc. | 1,180,178 | $7,034,000 | 0.64% |
TPG Group Holdings (SBS) Advisors, Inc. | 2,041,496 | $12,168,000 | 0.09% |
Eventide Asset Management | 392,513 | $2,288,000 | 0.08% |
Blackstone Inc. | 1,623,405 | $9,675,000 | 0.06% |
Granahan Investment Management | 141,012 | $840,000 | 0.05% |
Janney Montgomery Scott LLC | 46,861 | $279,000 | 0.00% |
BANK OF MONTREAL /CAN/ | 5,921 | $35,000 | 0.00% |
BlackRock Inc. | 15,755 | $94,000 | 0.00% |